The First International HPV Vaccine Information Clearinghouse
Child Health Safety
Posted on October 12, 2009 by childhealthsafety
Court evidence now available on-line at the University of California library shows drug giant Merck systematically targetted “hit-lists” of doctors to discredit, neutralise or destroy critics of the safety and effectiveness of Merck’s drugs.
VIHC Vaccine Injury Help Center
Posted on January 6, 2011 by RachelB
New side effects of the Gardasil vaccine–the drug marketed by Merck to reduce cervical cancer –are being brought to light. Thanks to patient rights groups, the symptoms listed on the drug’s insert, which include fainting, seizures and soreness at the injection site should have a few more. With thousands of women suffering side effects after any one of this three shot vaccination series, the truth about this dangerous drug goes beyond cervical cancer and has been linked to a variety of immune reactions including Guillain Barre Syndrome, and idiopathic thrombocytopenia purpura (ITP) a immune-mediated clotting disorder.
MHRA
Drug Safety Update
Article date: October 2010
Summary
No new risks have been identified for Cervarix despite significant exposure in the UK, and the balance of risks and benefits remains positive. This article summarises the safety experience of the past 2 years.
Time Magazine
Healthland
By Bonnie Rochman Friday, January 7, 2011
Girls really do care what their moms think, even once they’re all grown up. That’s the message that a new study is conveying after researchers found that college-age women are more likely to report getting the human papillomavirus (HPV) vaccine if they’d discussed it with their mothers.
Time Magazine
Healthland
By Meredith Melnick Friday, January 7, 2011
Sexual health specialists have long focused on circumcision as a potential safeguard against acquiring HIV. In fact, a 2006 clinical trial funded by the National Institutes of Health (NIH) found that medical circumcision reduced female-to-male transmission rates by 48% to 60% in two trials in Rakai, Uganda and Kisumu, Kenya.
